1832 Asset Management L.P. Eli Lilly & CO Transaction History

1832 Asset Management L.P.

$55.8 Billion
Q3 2024

A detailed history of 1832 Asset Management L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, 1832 Asset Management L.P. holds 395,666 shares of LLY stock, worth $316 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

395,666

Previous 642,431 38.41%

Holding current value

$316 Million

Previous $582 Million 39.73%

% of portfolio

0.63%

Previous 1.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $191 Million - $237 Million	-246,765 Reduced 38.41%	395,666 $351 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $84.8 Million - $106 Million	116,956 Added 22.26%	642,431 $582 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $111 Million - $149 Million	187,563 Added 55.51%	525,475 $409 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $237 Million - $279 Million	-451,130 Reduced 57.17%	337,912 $197 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $343 Million - $473 Million	789,042 New	789,042 $424 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $219 Million - $293 Million	625,048 Added 426.63%	771,556 $362 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $276 Million - $324 Million	-887,220 Reduced 85.83%	146,508 $50.3 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $8.3 Million - $9.67 Million	25,807 Added 2.56%	1,033,728 $378 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $142 Million - $162 Million	-479,682 Reduced 32.25%	1,007,921 $326 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $37.4 Million - $43.9 Million	-134,093 Reduced 8.27%	1,487,603 $482 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $368 Million - $458 Million	1,569,368 Added 2999.1%	1,621,696 $458 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $211 Million - $262 Million	-939,391 Reduced 94.72%	52,328 $14.4 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $78 Million - $96 Million	352,034 Added 55.03%	991,719 $228 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $79.3 Million - $103 Million	439,185 Added 219.04%	639,685 $145 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $16.2 Million - $21 Million	98,520 Added 96.61%	200,500 $37 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $13.3 Million - $17.6 Million	101,914 Added 154415.16%	101,980 $17.1 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $141 Million - $163 Million	-964,400 Reduced 99.99%	66 $10,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $49.1 Million - $59.1 Million	-359,720 Reduced 27.17%	964,466 $158 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $157 Million - $195 Million	1,321,470 Added 48655.01%	1,324,186 $185 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $3.42 Million - $4.23 Million	-31,956 Reduced 92.17%	2,716 $304,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $3.7 Million - $4.02 Million	34,606 Added 52433.33%	34,672 $3.85 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $166 Million - $194 Million	-1,497,347 Reduced 100.0%	66 $7,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $23.9 Million - $28.1 Million	-214,433 Reduced 12.53%	1,497,413 $194 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $164 Million - $184 Million	1,551,150 Added 965.27%	1,711,846 $198 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $13.7 Million - $17.1 Million	159,530 Added 13681.82%	160,696 $17.3 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $15.3 Million - $17.6 Million	-202,025 Reduced 99.43%	1,166 $105,000
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $15 Million - $17.7 Million	202,091 Added 18371.91%	203,191 $15.5 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $462,305 - $495,875	-5,642 Reduced 83.68%	1,100 $93,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $519,605 - $576,710	6,742	6,742 $562,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Account

1832 Asset Management L.P. Eli Lilly & CO Transaction History